Investing Profile

David Rubin

VCInvestor
Managing Director at Merck Global Health Innovation Fund
msdghifund.comUnited States
Photo of David Rubin, Managing Director at Merck Global Health Innovation Fund
Your Intro Paths to David Rubin

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find David Rubin on

cb
Current Investing Position
Merck Global Health Innovation Fund Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
17

David Rubin is on these Sector & Stage Rankings

David Rubin's Investments On Record (12)

CompanyStageDateRound SizeTotal Raised
N-Power Medicine
Series BMay 2024
Baseimmune
Series AFeb 2024$11M
$17M
Co-investors: Jamie Macfarlane (Creator Fund), Hussein Kanji (Hoxton Ventures)
Culmination Bio
Series ANov 2023$10M
$10M
Co-investors: Jack Boren
Octave
Series BJul 2023$33M
Series UnknownOct 2021
$150M
Co-investors: Mike Pellini (Section 32), Michael Rubin (Northpond Ventures), Julian Harris (Deerfield Management), Saurabh Bhansali (Health Velocity Capital)
Turbine
Series ANov 2022$21M
$130M
Co-investors: Hany Nada (ACME Capital), Alexandre Perrin (Scalebridge Capital), Christian Dahlen (Band of Angels), Vishal Gulati (Molten Ventures), Daniel Waterhouse (Balderton Capital), Anvesh Ramineni (MassMutual Ventures), Richard De Silva, Esther Dyson
PreciseDx
Series AJan 2022$11M
$14M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Verge Genomics
Series BDec 2021$98M
$130M
Co-investors: Lan Xuezhao (Basis Set Ventures), Henry McNamara (Great Oaks Venture Capital), Andrew Boszhardt (Great Oaks Venture Capital), Jesse Beyroutey (IA Ventures), Kimberly Vogel
Ciox Health
Private EquityJul 2019$30M
$30M